Cosmetic procedures continue to gain popularity, despite the downturn.
One of the most common reasons new patients give for polishing their appearance: To give themselves an edge in the job market.
Although one study shows that your looks can increase your paycheck, it’s unclear whether Botox can help you land the corner office.
A better way to gauge whether Botox and other injectables might be a worthy investment is to compare dollars to outcome.
Botox (and Dysport, another line-smoother derived from botulin) cost an average of $400 per treatment and last three to four months.
And because they act on the underlying muscles, using them on fine lines may prevent them from getting deeper, says Mt. Kisco, NY-based dermatologist David E. Bank, thus staving off the need (or desire) for an actual face lift.
By comparison, fillers (e.g. Restylane, Juvederm) plump up deeper wrinkles for an average of $550 per treatment, and the results last three to six months. But, unlike Botox, fillers have no preventive benefit.
Obviously, if you’re spending $1,200 a year on frown lines, you want to make sure the long-term payoff is better than banking that cash in your IRA.